SCHWARZ, Christopher Willy et al. Adverse Events and Immune Response in Psoriasis Patients Receiving Interleukin-17 Inhibitors. Acta Dermato-Venereologica, [S. l.], v. 105, p. adv43685, 2025. DOI: 10.2340/actadv.v105.43685. Disponível em: https://medicaljournalssweden.se/actadv/article/view/43685. Acesso em: 27 may. 2026.